|
NEDD4L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.62447832963153E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
6.85018708423968E-12 |
| Stage1-vs-Stage2 |
5.188400E-02 |
| Stage1-vs-Stage3 |
5.492100E-02 |
| Stage1-vs-Stage4 |
6.320300E-02 |
| Stage2-vs-Stage3 |
7.763000E-01 |
| Stage2-vs-Stage4 |
7.719800E-01 |
| Stage3-vs-Stage4 |
9.969600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
2.45979999702328E-08 |
| Caucasian-vs-AfricanAmerican |
2.756600E-01 |
| Caucasian-vs-Asian |
1.509250E-01 |
| AfricanAmerican-vs-Asian |
5.135400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.186400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.400510E-04 |
| Normal-vs-Extreme_Weight |
1.75415237890775E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
3.03590000028109E-07 |
| Normal_Weight-vs-Extreme_Weight |
5.002400E-01 |
| Normal_Weight-vs-Obese |
3.990000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.814000E-01 |
| Extreme_Weight-vs-Obese |
8.466600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.769200E-01 |
| Obese-vs-Extreme_Obese |
5.046200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.65399915985631E-11 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.66688884917221E-12 |
| Normal-vs-Age(81-100Yrs) |
5.6621374255883E-15 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.086400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.744600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.859400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.778000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.775600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.669630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
5.85070003555899E-09 |
| Normal-VS-KIRP CIMP |
1.99930072497523E-11 |
| Normal-VS-Unclassified PRCC |
1.63058455626697E-12 |
| Type1 PRCC-VS-Type2 PRCC |
6.328000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.998400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.839200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.925440E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.764800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.351570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| Normal-vs-N2 |
5.42400000025367E-07 |
| N0-vs-N1 |
2.870000E-01 |
| N0-vs-N2 |
4.342000E-01 |
| N1-vs-N2 |
7.341800E-01 |
|
|
